Skip to main
BCAB

BioAtla, Inc (BCAB)


$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy BioAtla, Inc (BCAB) Stock

About BioAtla, Inc (BCAB)

BioAtla, Inc. engages in the development of novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its CAB portfolio include MABs & ADCS, BA3011, and BA3021. The company was founded by Jay M. Short and Carolyn Anderson in March 2007 and is headquartered in San Diego, CA.
Market cap$7.36M
Yesterday's volume44
Revenue (TTM)$2M
Avg. daily volume51.42K
EBITDA (TTM)-$58.93M
Open$4.80
Price / earnings ratio-0.09x
Yesterday's range$4.2 - $4.9
Debt / equity
52 week range$3.92 - $71.5
5 year debt / equity-0.02x
Beta (LTM)1.01x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio0.37x
Ex-dividend date
Next earnings
Dividend payable date

Frequently Asked Questions (FAQ)

As of Apr 08, 2026, the market cap for BCAB stock is $7.36M

The current P/E ratio for BCAB stock is -0.09

The 52-week high for BCAB stock is $71.50. The current BCAB stock price $undefined is 100.00% below its 52-week high

The 52-week low for BCAB stock is $3.92. The current BCAB stock price $undefined has increased 100.00% from its 52-week low

No, the BCAB stock does not pay dividends to its shareholders

How to buy BCAB stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in BCAB stock

    Navigate to the Explore page. Then, type BCAB into the search bar. When you see BCAB stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased BCAB stock in your portfolio alongside the rest of your stocks, ETFs, crypto, bonds, options, and your high-yield cash account––all in one place on Public.

BioAtla, Inc Stock Earnings

The value each BCAB share was expected to gain vs. the value that each BCAB share actually gained.

BioAtla, Inc (BCAB) reported Q4 2025 earnings per share (EPS) of -$0.16, beating estimates of -$0.36 by 55.56%. In the same quarter last year, BioAtla, Inc's earnings per share (EPS) was -$0.30. BioAtla, Inc is expected to release next earnings on , with an earnings per share (EPS) estimate of -$0.37.

Buy BioAtla, Inc (BCAB) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.